Liver and biliary tract cancer trials in Singapore
13 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Singapore
- Age
- 18 years to 130 years
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- Where
- Singapore
- Age
- 18 years and over
- People
- 198 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07291076 · EU 2025-523602-33-00 - No phaseTaking peopleHistotripsy for Ablation of Liver Tumours in Asia
- Where
- Singapore
- Age
- 21 years to 99 years
- People
- 40
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT07428356 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Kent Ridge, Singapore
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Bukit Merah, Singapore
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 2Taking peopleNeoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
- Where
- Singapore
- Age
- 21 years and over
- People
- 60
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT04912765 - Phase 1/2Taking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Singapore
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - Phase 2Taking peopleDeep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
- Where
- Singapore
- Age
- 21 years to 90 years
- People
- 30
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT05516628 - No phaseNot yet taking people in SingaporeRestoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
- Where
- Singapore
- Age
- 40 years to 90 years
- People
- 90
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT07111130 - Phase 1Taking peopleSingle Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma
- Where
- Singapore
- Age
- 21 years to 99 years
- People
- 100
- Run by
- National University Hospital, Singapore
See details and how to joinNCT05687747 - Phase 1/2Taking peopleA Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
- Where
- Singapore
- Age
- 18 years to 70 years
- People
- 46 worldwide
- Run by
- SCG Cell Therapy Pte. Ltd.
See details and how to joinNCT05417932 - Phase 2Taking peopleA Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
- Where
- Singapore
- Age
- 21 years to 99 years
- People
- 360
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06422403 - Phase 1Taking peopleRedirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
- Where
- Singapore
- Age
- 21 years to 75 years
- People
- 10
- Run by
- Lion TCR Pte. Ltd.
See details and how to joinNCT04745403